|
시장보고서
상품코드
2050482
피브린 실란트 시장 : 제품 유형별, 원료별, 용도별, 제형별, 최종사용자별, 지역별Fibrin Sealant Market, By Product Type, By Source, By Application, By Formulation, By End User, By Geography |
||||||
피브린 실란트 시장은 2026년에 18억 4,000만 달러로 추정되고 있으며, 2033년까지 33억 4,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.9%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 18억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 8.90% | 예측 금액(2033년) | 33억 4,000만 달러 |
세계의 피브린 실란트 시장은 첨단 수술 및 상처 관리 산업에서 중요한 부문으로, 인간 또는 동물 유래의 피브리노겐 및 트롬빈 성분으로 만든 생체 접착제 제품을 포함하고 있습니다. 피브린 실란트는 자연 혈액 응고 캐스케이드의 마지막 단계를 모방하는 지혈제 역할을 하며, 안정적인 피브린 응고 덩어리를 형성하여 수술 중 빠른 지혈과 조직 봉합을 실현합니다. 이러한 생체적합성 제품들은 출혈 조절과 조직 접착 촉진에 탁월한 효능을 발휘하여 심혈관 수술, 정형외과, 일반외과, 외상 치료 등 다양한 의료 분야에서 큰 주목을 받고 있습니다.
이 시장에는 2성분 시스템, 단일 성분 제제, 즉시 사용형 등 다양한 제품 형태가 포함되어 있으며, 다양한 수술 요건과 적용 방법에 대응할 수 있습니다. 저침습 수술 기술의 보급 확대, 외과적 개입이 필요한 만성질환의 유병률 증가, 출혈성 질환에 취약한 고령 인구의 증가가 시장 확대를 견인하고 있습니다. 또한 피브린 실란트 제조 공정의 기술적 진보, 제품 안전성 향상, 기존 수술 용도를 넘어서는 적용 범위의 확대가 시장 성장에 기여하고 있으며, 피브린 실란트는 현대 외과 의료에서 필수적인 툴로 자리매김하고 있습니다.
시장 역학
세계의 피브린 실란트 시장의 시장 역학은 강력한 성장 요인, 중요한 억제요인 및 새로운 성장 기회와 같은 다각적인 요인에 의해 형성되고 있으며, 이러한 요인들이 종합적으로 시장의 궤도를 좌우하고 있습니다. 주요 시장 촉진요인으로는 고령화, 심혈관 질환, 정형외과 질환, 효과적인 지혈 솔루션을 필요로 하는 외상 사례의 증가로 인해 전 세계에서 수술 건수가 증가하고 있는 것을 들 수 있습니다. 최소침습 수술 기술의 보급과 함께 제한된 수술 공간에서 출혈을 관리하기 위해 피브린 실란트와 같은 고급 지혈제가 요구되고 있습니다. 또한 기존 봉합사에 비해 생체접착제의 임상적 이점에 대한 의료진의 인식이 높아지면서 시장 침투가 가속화되고 있습니다. 혈장 유래 제품에 수반되는 바이러스 감염 위험을 제거한 합성 및 재조합 피브린 실란트 개발 등 제품 제형에 대한 기술 혁신도 시장 성장을 더욱 촉진하고 있습니다.
그러나 기존 지혈법에 비해 높은 제품 비용, 생물제제에 대한 엄격한 규제 승인 절차, 인체 유래 성분에 의한 면역원성 반응 및 질병 전파 위험과 관련된 잠재적 안전성 우려 등 시장 확대에는 상당한 제약이 존재합니다. 특정 의료보험제도의 제한적인 보험급여 범위와 신흥 시장에서의 인지도 부족도 도입률을 제한하는 요인으로 작용하고 있습니다. 그럼에도 불구하고 상처 치유, 조직공학, 재생의료 분야에서의 적용 확대, 의료 인프라가 구축되고 있는 신흥 국가에서의 수요 증가, 새로운 전달 시스템 및 복합 제품 개발, 환자의 빠른 회복과 의료비 절감을 위한 효과적인 지혈 솔루션을 필요로 하는 외래 수술에 대한 대한 관심이 높아짐에 따라 큰 기회가 창출되고 있습니다.
이 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트를 제공합니다.
- 세계 피브린 실란트 시장의 주요 기업 개요을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 파라미터를 기반으로 정리하여 전해드립니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계의 피브린 실란트 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 피브린 실란트 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 피브린 실란트 시장 : 제품 유형별(2021-2033년)
제5장 세계의 피브린 실란트 시장 : 원료별(2021-2033년)
제6장 세계의 피브린 실란트 시장 : 용도별(2021-2033년)
제7장 세계의 피브린 실란트 시장 : 제형별(2021-2033년)
제8장 세계의 피브린 실란트 시장 : 최종사용자별(2021-2033년)
제9장 세계의 피브린 실란트 시장 : 지역별(2021-2033년)
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 분석 방법
KSA 26.06.10Fibrin Sealant Market is estimated to be valued at USD 1.84 Bn in 2026 and is expected to reach USD 3.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.84 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 3.34 Bn |
The global fibrin sealant market represents a critical segment within the advanced surgical and wound care industry, encompassing biological adhesive products derived from human or animal fibrinogen and thrombin components. Fibrin sealants function as hemostatic agents that mimic the final stages of natural blood coagulation cascade, forming stable fibrin clots to achieve rapid hemostasis and tissue sealing during surgical procedures. These biocompatible products have gained substantial traction across diverse medical specialties including cardiovascular surgery, orthopedic procedures, general surgery, and trauma care due to their superior efficacy in controlling bleeding and promoting tissue adhesion.
The market encompasses various product formulations including two-component systems, single-component preparations, and ready-to-use formats, catering to different surgical requirements and application methods. Growing adoption of minimally invasive surgical techniques, increasing prevalence of chronic diseases requiring surgical interventions, and rising geriatric population susceptible to bleeding disorders are driving market expansion. Additionally, technological advancements in fibrin sealant manufacturing processes, enhanced product safety profiles, and expanding applications beyond traditional surgical uses are contributing to market growth, positioning fibrin sealants as indispensable tools in modern surgical practice.
Market Dynamics
The global fibrin sealant market dynamics is shaped by multifaceted factors encompassing strong growth drivers, significant restraints, and emerging opportunities that collectively influence market trajectory. Primary market drivers include the escalating volume of surgical procedures worldwide, driven by aging demographics and increasing prevalence of cardiovascular diseases, orthopedic conditions, and trauma cases requiring effective hemostatic solutions. The growing adoption of minimally invasive surgical techniques necessitates advanced hemostatic agents like fibrin sealants to manage bleeding in confined surgical spaces, while raising awareness among healthcare professionals about the clinical benefits of biological adhesives over traditional suturing methods accelerates market penetration. Technological innovations in product formulation, including development of synthetic and recombinant fibrin sealants that eliminate viral transmission risks associated with plasma-derived products, further propel market growth.
However, market expansion faces notable restraints including high product costs compared to conventional hemostatic methods, stringent regulatory approval processes for biological products, and potential safety concerns related to immunogenic reactions and disease transmission risks from human-derived components. Limited reimbursement coverage in certain healthcare systems and inadequate awareness in emerging markets also constrain adoption rates. Nevertheless, substantial opportunities emerge from expanding applications in wound healing, tissue engineering, and regenerative medicine, growing demand in emerging economies with improving healthcare infrastructure, development of novel delivery systems and combination products, and increasing focus on outpatient surgical procedures requiring effective hemostatic solutions that enable faster patient recovery and reduced healthcare costs.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fibrin sealant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Baxter International Inc., Johnson and Johnson (Ethicon, Inc.), CSL Behring, Grifols S.A., Pfizer Inc., Takeda Pharmaceutical Company Limited, Vivostat A/S, Stryker Corporation, Asahi Kasei Corporation, Octapharma AG, Bayer AG, Shanghai RAAS, Hualan Biological, Bioseal Biotech, and Harbin Hanbang Medical.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global fibrin sealant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibrin sealant market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Two-Component Fibrin Sealants
- Single-Component Fibrin Sealants
- Patch-Based Fibrin Sealants
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Autologous (patient-derived)
- Allogeneic (donor-derived)
- Recombinant
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- General Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Neurological Surgery
- Plastic and Reconstructive Surgery
- Other Specialized Surgeries (e.g., urology, thoracic, gynecology)
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Liquid Form
- Powder Form
- Spray/Aerosol Form
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Research and Academic Institutes
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter International Inc.
- Johnson & Johnson (Ethicon, Inc.)
- CSL Behring
- Grifols S.A.
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Vivostat A/S
- Stryker Corporation
- Asahi Kasei Corporation
- Octapharma AG
- Bayer AG
- Shanghai RAAS
- Hualan Biological
- Bioseal Biotech
- Harbin Hanbang Medical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Fibrin Sealant Market, By Product Type
- Global Fibrin Sealant Market, By Source
- Global Fibrin Sealant Market, By Application
- Global Fibrin Sealant Market, By Formulation
- Global Fibrin Sealant Market, By End User
- Global Fibrin Sealant Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Fibrin Sealant Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Two-Component Fibrin Sealants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Single-Component Fibrin Sealants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Patch-Based Fibrin Sealants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Fibrin Sealant Market, By Source, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Autologous (patient-derived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Allogeneic (donor-derived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Recombinant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Fibrin Sealant Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurological Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Plastic and Reconstructive Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Specialized Surgeries (e.g., urology, thoracic, gynecology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Fibrin Sealant Market, By Formulation, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Liquid Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Powder Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Spray/Aerosol Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Fibrin Sealant Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Fibrin Sealant Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson (Ethicon, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grifols S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vivostat A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Octapharma AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shanghai RAAS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hualan Biological
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioseal Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Harbin Hanbang Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
